
浏览全部资源
扫码关注微信
安徽医科大学 第一附属医院,合肥 230001
[第一作者] 李倩,住院医师,从事中西医结合心血管内科临床诊疗工作,E-mail:ayhwx57@163.com
*韩卫星,教授,主任医师,从事心血管内科临床、教学、科研工作,E-mail:ayhwx57@163.com
收稿日期:2019-06-12,
网络出版日期:2019-09-25,
纸质出版日期:2020-02-05
移动端阅览
李倩, 胡泽平, 韩卫星. 六味地黄丸合丹栀逍遥散加减治疗H型高血压阴虚阳亢证的临床观察[J]. 中国实验方剂学杂志, 2020,26(3):90-95.
Qian LI, Ze-ping HU, Wei-xing HAN. Clinical Efficacy of Liuwei Dihuangwan Combined with Danzi Xiaoyaosan on H-type Hypertension with Syndrome of Yin Deficiency and Yang Hyperactivity[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(3): 90-95.
李倩, 胡泽平, 韩卫星. 六味地黄丸合丹栀逍遥散加减治疗H型高血压阴虚阳亢证的临床观察[J]. 中国实验方剂学杂志, 2020,26(3):90-95. DOI: 10.13422/j.cnki.syfjx.20192334.
Qian LI, Ze-ping HU, Wei-xing HAN. Clinical Efficacy of Liuwei Dihuangwan Combined with Danzi Xiaoyaosan on H-type Hypertension with Syndrome of Yin Deficiency and Yang Hyperactivity[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(3): 90-95. DOI: 10.13422/j.cnki.syfjx.20192334.
目的:
2
探讨六味地黄丸合丹栀逍遥散加减治疗H型高血压阴虚阳亢证的疗效及对血管内皮功能和炎症因子的影响。
方法:
2
将150例患者随机按数字表法分为对照组和观察组各75例。对照组口服马来酸依那普利叶酸片,1片/次,1次/d,血压还不能控制者加服硝苯地平缓释片,20 ~30 mg/次,2次/d。观察组西医治疗措施同对照组,并内服六味地黄丸合丹栀逍遥散加减,1剂/d。两组疗程均为连续治疗12周。每日偶测血压,比较治疗前后收缩压(SBP),舒张压(DBP)水平和血压达标情况;进行治疗前后动态血压监测,记录24 h收缩压标准差(24 h SSD),24 h舒张压标准差(24 h DSD),24 h平均收缩压(24 h SBP),24 h平均舒张压(24 h DBP);进行治疗前后踝臂指数(ABI)和肱动脉血流介导血管舒张功能(FMD)评价;进行治疗前后阴虚阳亢证评分;检测治疗前后白细胞介素-6(IL-6),IL-10,高敏C反应蛋白(hsCRP)和同型半胱氨酸(Hcy)水平。
结果:
2
观察组患者SBP,DBP,24 h SSD,24 h DSD,24 h SBP和24 h DBP水平均较对照组降低(
P
<
0.01);观察组偶测血压达标率为81.19%,高于对照组的66.98%(
χ
2
=29.81,
P
<
0.01);观察组患者ABI和FMD均高于对照组(
P
<
0.01),阴虚阳亢证评分低于对照组(
P
<
0.01);观察组患者Hcy,瘦素,IL-6,hs-CRP水平均低于对照组(
P
<
0.01),IL-10水平高于对照组(
P
<
0.01)。
结论:
2
在降压和补充马来酸依那普利叶酸片治疗的基础上,六味地黄丸合丹栀逍遥散加减治疗H型高血压阴虚阳亢证患者,可更好控制血压和Hcy水平,减轻血压变异性,提高血压达标率,改善临床症状,改善血管内皮功能,并能调节炎症因子。
Objective:
2
To discuss the clinical efficacy of Liuwei Dihuangwan combined with Danzi Xiaoyaosan on H-type hypertension with syndrome of Yin deficiency and Yang hyperactivity and its effect on vascular endothelial function and inflammatory factors.
Method:
2
One hundred and fifty patients were randomly divided into control group (75 cases) and observation group (75 cases) by random number table.Patients in control group got enalapril maleate and folic acid tablets
1 tablet/time
1 time/day
and patients with uncontrollable blood pressure were also given nifedipine sustained-release tablets
20-30 mg/time
2 times/days.In addition of the therapy of control group
patients in observation group were also given modified Liuwei Dihuangwan combined with Danzi Xiaoyaosan
1 dose/day.The course of treatment was 12 weeks.Before and after treatment
systolic blood pressure (SBP)
diastolic blood pressure (DBP) and up-to-standard blood pressure were detected.And ambulatory blood pressure
standard deviation of 24-hours systolic blood pressure (24 h SSD)
standard deviation of 24-hour diastolic blood pressure 24 h DSD)
24 h mean systolic blood pressure (24 h SBP)
24 h mean diastolic blood pressure (24 h DBP) were recorded.And ankle brachial index (ABI) and brachial artery blood flow mediated diamete (FMD) were discussed
syndrome of Yin deficiency and Yang hyperactivity was scored
and levels of iterleukin-6 (IL-6)
IL-10
high-sensitivity C-reactive protein (hsCRP) and homocysteine (Hcy) were detected.
Result:
2
The levels of SBP
DBP
24 h SSD
24 h DSD
24 h SBP and 24 h DBP were all lower than those in control group (
P
<
0.01). The achievement rate of accidental blood pressure in observation group was 81.19%
which was higher than 66.98% in control group (
χ
2
=29.81
P
<
0.01). And levels of ABI
FMD and IL-10 were higher than those in control group (
P
<
0.01)
while the score of syndrome of Yin Deficiency and Yang Hyperactivity and the levels of Hcy
leptin
IL-6 and hs-CRP were lower than those in control group (
P
<
0.01).
Conclusion:
2
In addition to the therapy of antihypertensive and folic acid
Liuwei Dihuangwan combined with Danzi Xiaoyaosan can be given to control the level of blood pressure and Hcy
relieve the variability of blood pressure
alleviate clinical symptoms
raise the rate of achievement rate of blood pressure
improve the function of vascular endothelium
and regulate inflammatory factors.
李建平 , 卢新政 , 霍勇 , 等 . H型高血压诊断与治疗专家共识 [J]. 中华高血压杂志 , 2016 , 24 ( 2 ): 123 - 127 .
孙宁玲 , 李建平 , 卢新政 , 等 . H型高血压诊断标准依据解读 [J]. 中华高血压杂志 , 2017 , 25 ( 6 ): 508 - 510 .
《中国高血压防治指南》修订委员会 . 中国高血压防治指南(2018年修订版) [J]. 中国心血管杂志 , 2019 , 24 ( 1 ): 24 - 56 .
马骁 , 甘庆雷 , 阿里米江 , 等 . H型高血压中西医临床研究进展 [J]. 新疆中医药 , 2019 , 37 ( 3 ): 93 - 96 .
王强 , 何劲松 , 王庆高 , 等 . H型高血压与中医证型的相关性探讨 [J]. 辽宁中医杂志 , 2011 , 38 ( 11 ): 2226 - 2227 .
刘巍 , 熊兴江 , 王阶 . 论六味地黄丸在高血压病治疗中的运用 [J]. 中华中医药杂志 , 2013 , 28 ( 11 ): 3329 - 3333 .
李增明 . 邢月朋运用丹栀逍遥散治疗早期高血压48例临床观察 [J]. 时珍国医国药 , 2015 , 26 ( 2 ): 476 - 477 .
何剑成 , 董滟 , 董慧君 . 六味地黄丸对早期糖尿病肾病合并高同型半胱氨酸血症患者肾功能影响的临床研究 [J]. 时珍国医国药 , 2009 , 20 ( 2 ): 380 - 381 .
李璐君 . 丹栀逍遥散联合艾司西酞普兰片治疗缺血性脑卒中后抑郁症对患者总体康复的影响 [J]. 中国实用神经疾病杂志 , 2015 , 18 ( 21 ): 6 - 8 .
肖林 , 卢丹 , 黄焯明 , 等 . H型高血压与血管内皮功能和主动脉顺应性的相关性 [J]. 广东医学 , 2017 , 38 ( 13 ): 2002 - 2004 .
A Towfighi , M Daniela , O Bruce . Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study [J]. J Neurol Sci , 2010 , 298 ( 1 ): 153 - 157 .
杨英 , 杨俊 . 同型半胱氨酸与心血管疾病关系的研究进展 [J]. 临床心血管病杂志 , 2017 , 33 ( 2 ): 106 - 109 .
孙亚楠 , 祖力胡马尔·玉素甫 , 帕力旦·吾布尔 . H型高血压的中西医研究进展 [J]. 新疆中医药 , 2019 , 37 ( 2 ): 160 - 163 .
宋林鸿 , 董波 . 高同型半胱氨酸血症相关性高血压的中医研究概况 [J]. 中西医结合心脑血管病杂志 , 2019 , 17 ( 5 ): 706 - 707 .
王杰 , 顾月星 . H型高血压中医证素的聚类研究 [J]. 中国继续医学教育 , 2017 , 9 ( 3 ): 173 - 174 .
何佳 , 张莉晶 , 刘雯 . 化痰脉通片对H型高血压痰瘀互结证患者血压及踝臂指数变化的影响 [J]. 广州中医药大学学报 , 2019 , 36 ( 1 ): 26 - 31 .
徐彤彤 , 武琦 , 吕祥威 , 等 . 马来酸依那普利叶酸片对H型高血压患者血清瘦素水平的影响 [J]. 中国实验方剂学杂志 , 2013 , 19 ( 10 ): 291 - 294 .
傅广 , 马丽霞 , 汤华 , 等 . H型高血压患者同型半胱氨酸与血压变异性和炎症介质的相关性 [J]. 中国循证心血管医学杂志 , 2015 , 7 ( 3 ): 345 - 348 .
黄强 , 李美茹 . 叶酸联合常规药物对H型高血压合并颈动脉粥样硬化患者Hcy代谢、炎症反应、斑块性质的影响 [J]. 海南医学院学报 , 2017 , 23 ( 13 ): 1773 - 1775,1779 .
0
浏览量
18
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621